Synthetic Biology

The development of synthetic intramembrane proteolysis receptors (SNIPRs) engineered by researchers in the United States could be a game-changer for CAR T-cell cancer therapies. This groundbreaking advancement introduces a novel methodology to enhance the precision and safety of CAR T-cell

Switzerland has established itself as a global leader in the biotech industry, making significant advancements in areas such as cancer treatment, immunotherapy, gene and cell therapy, and more. With a strong focus on personalized and precision medicine, the Swiss biotech sector thrives on

Synthetic biology, commonly known as synbio, is at the cutting edge of biotechnology, offering revolutionary solutions for various industries. Dr. John Cumbers, a pioneering figure in this field and the Founder and CEO of SynBioBeta LLC, provides profound insights into how synbio can address

The dawn of a food revolution is upon us, with synthetic biology at the helm, ready to address critical issues like resource scarcity and population growth. The anticipated SynBioBeta 2024's food and ag panel sessions are likely to showcase significant advances in synthetic biology, signaling

Synthetic biology stands at the vanguard of biotechnology, offering a future where the creation and manipulation of life are not confined to the boundaries of natural evolution. Unlike traditional gene editing, which typically involves small-scale modifications, synthetic biology ambitiously seeks

The fusion of synthetic biology (SynBio) with architecture is marking the beginning of a revolutionary shift towards eco-friendly building methods. At the forefront is Ginger Dosier with her pioneering company, Biomason; she represents the future of green construction. SynBio's integration